DGAP-PVR: HOCHTIEF Aktiengesellschaft: Release according to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-PVR: HOCHTIEF Aktiengesellschaft: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

HOCHTIEF Aktiengesellschaft 28.10.2013 15:18 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification of voting rights pursuant to sec. 25 WpHG We received the following notification pursuant to sec. 25 WpHG on October 24, 2013: 1. Listed company: HOCHTIEF Aktiengesellschaft Opernplatz 2, 45128 Essen, Deutschland 2. Notifier: ACS, Actividades de Construcción y Servicios, S.A., Madrid, Spanien 3. Triggering event: Exceeding Threshold 4. Threshold(s) crossed or reached: 5%, 10%, 15%, 20%, 25%, 30% and 50% 5. Date at which the threshold is crossed or reached: 18.10.2013 6. Total amount of voting rights: 58.54% (equals 45075605 voting rights) calculated from the following total number of voting rights issued: 76999999 7. Detailed information on the voting rights proportion: Voting rights proportion based on financial/other instruments pursuant to sec. 25 WpHG: 0.04% (equals 28600 voting rights) thereof held indirectly: 0% (equals 0 voting rights) Voting rights pursuant to sec. 21, 22 WpHG: 58.50% (equals 45047005 voting rights) 8. Detailed information on financial/other instruments pursuant to sec. 25 WpHG: ISIN or name/description of the financial/other instrument: Exercise period: von 18.10.2013 bis 29.05.2014 Maturity: 29.05.2014 Expiration date: 29.05.2014 28.10.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: HOCHTIEF Aktiengesellschaft Opernplatz 2 45128 Essen Germany Internet: www.hochtief.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investigation of Stock Transactions: TASK, VBTX, TURN Insights

Updated Category News Views 125

Financial Investigations for Shareholders of TASK, VBTX, and TURN Halper Sadeh LLC is actively investigating several companies regarding potential violations of federal securities laws affecting shareholders. The investigations focus on significant transactions involving TaskUs, Veritex Holdings, and 180 Degree Capital Corp. TaskUs, Inc. and Its Acquisition by Blackstone...

Continue Reading
Comprehensive Analysis of NVIDIA in the Semiconductor Market

Updated Category News Views 678

Understanding NVIDIA's Position in the Semiconductor Sector In today's fast-paced business environment, it is crucial for investors and industry followers to conduct in-depth analyses of key companies. This article offers a detailed comparison of NVIDIA (NASDAQ: NVDA) with its main competitors in the Semiconductors & Semiconductor Equipment sector. By looking at important...

Continue Reading
Invivyd Set to Showcase PEMGARDA™ Findings at Upcoming Event

Updated Category News Views 54

Invivyd Prepares for IDWeek 2024 Presentations Invivyd, Inc. (NASDAQ: IVVD) is an innovative biopharmaceutical company focusing on creating solutions for serious viral infections. As they gear up for their participation in IDWeek 2024, they will be unveiling exciting new data concerning their investigational monoclonal antibody, PEMGARDA™ (pemivibart). The conference is...

Continue Reading
The Rising Stars: Growth Potential of Key Investments

Updated Category News Views 95

Carnival made waves post-pandemic as it clawed its way back from meme stock purgatory. Traders watched the cruise line stumble but now see flickers of recovery amidst hefty debt burdens that peaked around $35 billion. Sure, they pulled in a whopping $1.7 billion net income in the last quarter, but those profit forecasts? All over the place—talk about a mixed bag. And...

Continue Reading
PharmAla Partners with Logistics Expert for Clinical Trials

Updated Category News Views 114

PharmAla Forms Strategic Alliance for Enhanced US Distribution PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a dedicated biotechnology company, is excited to share its latest strategic move aimed at improving service delivery in the United States. The company has engaged a trusted third-party logistics partner, specialized...

Continue Reading